Amelioration of methotrexate-induced enteritis by melatonin in rats

Cell Biochemistry and Function

Volumn 22, Issue 3, 2004, Pages 169-178

  Jahovic, Nermina ^a   Şener, Göksel ^a   Çevik, Hülya ^a   Ersoy, Yasemin ^a   Arbak, Serap ^a   Yeǧen, Berrak Ç ^a,b  

^a MARMARA UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Enteritis; Melatonin; Methotrexate; Myeloperoxidase activity; Na + K+ ATPase activity

Indexed keywords

ADENOSINE TRIPHOSPHATASE; GLUTATHIONE; MALONALDEHYDE; MELATONIN; METHOTREXATE; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DEGENERATION; DESQUAMATION; DIARRHEA; DRUG EFFECT; ENTERITIS; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL TOXICITY; HISTOPATHOLOGY; HORMONE ACTION; INTESTINE EPITHELIUM CELL; INTESTINE INJURY; INTESTINE MOTILITY; INTESTINE MUCOSA; INTESTINE TRANSIT TIME; MALABSORPTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RAT; SCANNING ELECTRON MICROSCOPY; WEIGHT REDUCTION;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; DISEASE MODELS, ANIMAL; ENTERITIS; FREE RADICAL SCAVENGERS; GLUTATHIONE; INTESTINAL MUCOSA; MALONDIALDEHYDE; MELATONIN; METHOTREXATE; NA(+)-K(+)-EXCHANGING ATPASE; PEROXIDASE; RATS; WEIGHT LOSS;

EID: 2442667762     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.1071     Document Type: Article

References (42)

1. Helen STE, Schiano TD, Kuan SF, Hanauer SB, Conjeevaram HS, Baker AL. Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease. Am J Gastroenterol 2000; 95: 3150-3156.
2. Altman GG. Changes in the mucosa of the small intestine following methotrexate administration or abdominal X-irradiation. Am J Anat 1974; 140: 263-279.
3. Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chabner BA. The pharmacology and clinical use of methotrexate. N Engl J Med 1983; 309: 1094-1104.
4. Nagakubo J, Tomimatsu T, Kitajima M, Takayama H, Aimi N, Horie T. Characteristics of transport of fluoresceinated methotrexate in rat small intestine. Life Sci 2001; 69: 739-747.
5. Vogel WH, Snyder R, Schulman MP. The inhibition of dehydrogenases by folic acid and several of its analogs. Biochim Biophys Res Comm 1963; 10: 97-101.
6. Babiak RMV, Campello AP, Camieri EGS, Oliveira MBM. Methotrexate: pentose cycle and oxidative stress. Cell Biochem Funct 1998; 16: 283-293.
7. Caetano NN, Campello AP, Carnieri EGS, Kluppel MLW, Oliveira MBM. Effects of methotrexate (MTX) on NAD(P)+ dehydrogenases of HeLa cells: malic enzymes, 2-oxoglutarate and isocitrate dehydrogenases. Cell Biochem Funct 1997; 15: 259-264.
8. Reiter RJ, Tan DX, Manchester LC, Qi W. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species. A review of the evidence. Cell Biochem Biophysics 2001; 34: 237-256.
9. Reiter RJ, Maestroni GJM. Melatonin in relation to the antioxidative defense and immune systems: possible implications for cell and organ transplantation. J Mol Med 1999; 77: 36-39.
10. Bubenik GA. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 2002; 47: 2336-2348.
11. Motilva V, Cabeza J, Alarcon de la Lastra C. New issues about melatonin and its effects on the digestive system. Curr Pharm Des 2001; 7: 909-931.
12. Ünlüer EE, Alican İ, Yeǧen C, Yeǧen BÇ. The delays in intestinal motility and neutrophil infiltration following burn injury in rats involve endogenous endothelins. Burns 2000; 26: 335-340.
13. Hillegas LM, Griswold DE, Brickson B, Albrightson-Winslow C. Assesment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods 1990; 24: 285-295.
14. Beuge JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-311.
15. Beutler E. Glutathione in red blood cell metabolism. In A Manual of Biochemical Methods, Beutler E (ed.). Grune & Stratton: New York, 1975; 112-114.
16. Kim YK, Lee SH, Goldinger JM, Honk SK. Effect of ethanol on organic ion transport in rabbit kidney. Toxicol Appl Pharmacol 1986; 86: 411-420.
17. Fiske CH, SubbaRow Y. The colorimetric determination of phosphorus. J Biol Chem 1925; 66: 375-400.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
19. Oktar BK, Gülpinar MA, Ercan F, Cingi A, Alican İ, Yeǧen BÇ. Beneficial effects of glycocholic acid (GCA) on gut mucosal damage in bile duct ligated rats. Inflammation 2001; 25: 311-318.
20. 1-mRNA and protein levels in rat small intestine in experimental ileitis. Am J Physiol 1995; 269 (Gastrointest Liver Physiol 32): G666-G675.
21. 1-mRNA and protein levels in rat small intestine in experimental ileitis. Am J Physiol 1995; 269 (Gastrointest Liver Physiol 32): G666-G675.
22. Spies M, Chappel VL, Dasu MR, Herndon DN, Thompson JC, Wolf SE. Role of TNF-α in gut mucosal changes after severe burn. Am J Physiol Gastrointest Liver Physiol 2002; 283: G703-G708.
23. McGinnes JE, Proctor PH, Demopoulos HB, Hokanson JA, Kirkpatrick DS. Amelioration of cis-platinum nephrotoxicity by orgotein (superoxide dismutase). Physiol Chem Phys 1978; 10: 267-277.
24. Tsurusawa M, Saeki K, Fujimoto T. Differential induction of apoptosis on human lymphoblastic leukemia Nalm-6 and Molt-4 cells by various antitumor drugs. Int J Hematol 1997; 66: 79-88.
25. Heenen M, Laporte M, de Graef C. Methotrexate induces apoptotic cell death in human keratinocytes. Arch Dermatol Res 1998; 290: 240-245.
26. Reiter RJ, Tan DX, Osuna C, Gitto E. Actions of melatonin in the reduction of oxidative stress. J Biomed Sci 2000; 7: 444-458.
27. Vijayalaxmi, Meltz ML, Reiter RJ, Herman TS. Melatonin and protection from genetic damage in blood and bone marrow: whole-body irradiation studies in mice. J Pineal Res 1999; 27: 221-225.
28. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
29. Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 1994; 55: PL 271-276.
30. Pierrefiche G, Topall G, Courboin G, Henriet I, Laborit H. Antioxidant activity of melatonin in mice. Res Comm Chem Path Pharm 1993; 80: 211-223.
31. Karbownik M, Reiter RJ, Garcia JJ, Tan DX, Qi W, Manchester LC. Melatonin reduces rat hepatic macromolecular damage due to oxidative stress caused by δ-aminolevulinic acid. Biochim Biophys Acta 2000; 1523: 140-146.
32. Benot S, Gobema R, Reiter RJ, Garcia-Maurino S, Osuna C, Guerrero JM. Physiological levels of melatonin contribute to the antioxidant capacity of human serum. J Pineal Res 1999; 27: 59-64.
33. Zimmerman BJ, Granger N. Reperfusion injury. Surg Clin North Am 1992; 72: 65-83.
34. Cunningham D, Morgan RJ, Mills PR, et al. Functional and structural changes of the human proximal small intestine after cytotoxic therapy. J Clin Pathol 1985; 38: 265-270.
35. Phelan MJ, Taylor W, van Heyningen C, Wiliams E, Thompson RN. Intestinal absorption in patients with rheumatoid arthritis treated with methotrexate. Clin Rheumatol 1993; 12: 223-225.
36. van't Land B, Meijer HP, Frerich J, et al. Transforming growth factor-beta2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling. Br J Cancer 2002; 87: 113-118.
37. Xian CJ, Howarth GS, Mardell CE, et al. Temporal changes in TFF3 expression and jejunal morphology during methotrexate-induced damage and repair. Am J Physiol 1999; 277: G785-G795.
38. Cuzzocrea S, Mazzon E, Seraino I, et al. Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. J Pineal Res 2001; 30: 1-12.
39. Brzowska I, Konturek PC, Brzowski T, et al. Role of prostaglandins, nitric oxide, sensory nerves and gastrin in acceleration of ulcer healing by melatonin and its precursor, L-tryptophan. J Pineal Res 2002; 32: 149-162.
40. +) ATPase along the villus crypt-axis in the rabbit small intestine. Biochim Biophys Acta 1984; 771: 35-41.
41. Bubenik GA. Localization, physiological significance and possible clinical implication of gastrointestinal melatonin. Biol Signals Recept 2001; 10: 350-366.
42. Barajas-Lopez C, Peres AL, Espinosa-Luna R, Reyes-Vazquez C, Prieto-Gomez B. Melatonin modulates cholinergic transmission by blocking nicotinic channels in the guinea-pig submucous plexus. Eur J Pharmacol 1996; 312: 319-325.